Regenerative medicine: what it does and when it applies

Regenerative medicine: what it is and what it involves

Regenerative medicine is the field of medicine that works with the body's own repair mechanisms to address tissue deterioration. What it does, what it involves, and when it is indicated are the three questions we hear most often before an assessment, and this article answers them with the same clinical standard we apply in consultation: without oversimplifying and without making promises.

The field spans several lines of work: cell therapy (which includes the use of stem cells), platelet-rich plasma, and hyperbaric oxygenation under medical supervision, among others. Each has distinct indications, distinct supporting evidence, and a different candidacy profile. Treating them as equivalent is the first mistake that leads to misaligned expectations.

What regenerative medicine does: what the evidence supports

Regenerative medicine addresses tissue deterioration and the loss of function that accompanies aging or injury. What the evidence supports today, with varying degrees of strength depending on the indication, is its application to damaged musculoskeletal tissue, skin with chronic deterioration, and certain post-surgical or post-traumatic recovery processes.

That said, the word "supports" requires nuance. There are indications with documented clinical history, indications in active research, and applications that do not yet have sufficient evidence to be recommended outside a study protocol. In daily clinical practice, that distinction matters more than any list of conditions.

The indication is not defined by the name of the treatment. It is defined by the individual assessment: the affected tissue, the patient's functional status, and the specific therapeutic objective.

Cell therapy with stem cells: indication and limits

Stem cell therapy is the line of regenerative medicine that generates the most expectations and also the most confusion. In general terms, it works with cells that have the capacity to differentiate and to modulate inflammatory processes. There are applications with documented clinical history, such as certain hematological diseases, and applications under study for joint tissue and other systems.

What is under investigation remains under investigation. That means that outside a formal study protocol, candidacy for cell therapy is assessed case by case with strict clinical judgment. To understand what distinguishes a clinic with clinical criterion from one that lacks it, the article on how to evaluate a stem cell therapy clinic in Mexico describes exactly that.

Not everyone who seeks regenerative medicine is a candidate for cell therapy. And not everyone who is not a candidate for cell therapy is excluded from the field: the other lines of work may be the correct indication.

Platelet-rich plasma: what is accepted and what remains under study

Platelet-rich plasma is obtained from a blood sample drawn from the patient and concentrates growth factors that participate in tissue repair. Its use in musculoskeletal tissue, tendons, and skin has a more extensive clinical history than other lines in the field.

The indications with the most documented history include tendon injuries, joint deterioration, and certain skin rejuvenation protocols. Even so, the response varies according to the tissue, the severity of the damage, and the patient's overall health status. Some indications remain under investigation, and others lack sufficient evidence.

A point that comes up frequently in consultation: variability in preparation protocols influences the clinical outcome. Not all procedures labeled "platelet-rich plasma" are equivalent.

Hyperbaric oxygenation under medical supervision

Hyperbaric oxygenation consists of breathing oxygen at a controlled concentration and pressure in an enclosed environment. Its approved indications include carbon monoxide poisoning, difficult-to-heal wounds, and certain infections. Its use as support in recovery and longevity protocols remains an area of active study.

Medical supervision is not a formality: it defines the dosage, the number of sessions, and the exclusion criteria. There are conditions in which hyperbaric oxygenation is contraindicated and others in which the indication is clear. That distinction is established by the prior assessment, not by the patient.

When regenerative medicine is not indicated

Regenerative medicine is not a field without limits. There are conditions in which none of its lines of work has a supported indication, and there are patient profiles in which the risks outweigh any possible benefit. That is the part that appears least in searches and carries the most weight in the clinical decision.

As a general standard: if someone offers regenerative medicine for any condition, without a prior assessment and without describing exclusion criteria, that is not clinical judgment. It is something else.

The smallest intervention that responsibly addresses the objective is always the right one. Sometimes that means not intervening.

What this field does not treat

Regenerative medicine has no supported indication as a primary treatment for complex systemic diseases, acute processes, or conditions that require specialized management from another discipline. The field works with the body's repair capacity, and that capacity has real biological limits.

It also does not replace the management of established chronic diseases. It may be part of a comprehensive plan, but never the sole axis. When a patient arrives expecting regenerative medicine to resolve a condition that another specialist could not, an honest assessment sometimes includes a redirection.

What regenerative medicine involves: assessment as the starting point

Regenerative medicine, in responsible practice, always begins with an assessment. Not with a treatment session or a predetermined protocol. The assessment establishes the therapeutic objective, identifies the relevant biomarkers, defines the indication, and determines whether a contraindication exists.

At Longevia Medical, that assessment can be in person at Puerto Cancún or remote. The resulting plan is individual and delivered in writing: protocol, number of sessions, follow-up criteria. Care includes medical supervision at every stage, including follow-up when the patient returns home.

flowchart TD
    A["Initial consultation: in person or remote"] --> B["Clinical assessment and biomarker review"]
    B --> C["Definition of therapeutic objective"]
    C --> D{"Is there an indication?"}
    D -->|"Yes"| E["Individual written plan: protocol and number of sessions"]
    D -->|"No"| F["Redirection or follow-up without intervention"]
    E --> G["Protocol start under medical supervision"]
    G --> H["Ongoing follow-up, including remotely"]

What a written plan includes

A written plan in regenerative medicine specifies the indication, the chosen line of work, the number of sessions or applications, the parameters to be measured during follow-up, and the criteria that would lead to adjusting or discontinuing the protocol. It is not a consent document: it is the working tool of the clinical team and the patient.

Body composition, when it is part of the longevity assessment, is measured with InBody. That data forms part of the follow-up record and allows the response to the protocol to be compared over time.

Follow-up as part of the protocol

Follow-up is not an optional step at the end. It is the only way to determine whether the indication was correct and whether the response is as expected. In regenerative medicine, changes in biomarkers and tissue function are not always immediate, and continuous medical supervision is what makes it possible to distinguish an ongoing response from an absence of response.

When the patient returns to their city, follow-up continues. Distance does not interrupt the clinical relationship.

Regenerative medicine and longevity: what is known and what is being studied

The intersection of regenerative medicine and longevity is one of the most active areas in current biomedical research. What is known is that certain deterioration processes associated with aging, such as loss of muscle mass, joint deterioration, and a decline in tissue repair capacity, can be addressed with tools from this field.

What remains under investigation is the magnitude of the effect, the duration of the response, and which patient profiles benefit most from each protocol. No one can promise that with the data available today. What can be done is to design a protocol with a clear objective, measure it, and adjust it.

Longevity is not a state to be reached. It is a set of processes that are monitored, measured, and adjusted over time.

The clinical lead for the regenerative medicine area at Longevia Medical is Dr. María Guadalupe Navarro Barrientos, Physician and Homeopath, with a Master's degree in Molecular Biomedicine and a Doctorate in Medical Research, all three from the IPN.

Frequently asked questions about regenerative medicine

What exactly does regenerative medicine do?

It addresses tissue deterioration through the body's own repair mechanisms. Its main lines of work are cell therapy, platelet-rich plasma, and hyperbaric oxygenation. The specific indication depends on the affected tissue and the therapeutic objective, and is defined in the medical assessment.

What does regenerative medicine involve in practice?

In practice, regenerative medicine begins with an assessment that defines the indication and the protocol. Depending on the case, it may include platelet-rich plasma sessions, cell therapy, or hyperbaric oxygenation. The plan is delivered in writing and includes medical supervision at every stage.

How long does the effect of platelet-rich plasma last?

The duration of the effect varies according to the tissue treated, the severity of the damage, and the patient's overall health status. There is no universal duration. Clinical follow-up makes it possible to identify whether the response is maintained or whether an adjustment to the protocol is needed.

What does regenerative medicine not treat?

Regenerative medicine has no supported indication as a primary treatment for complex systemic diseases, acute processes, or conditions that require specialized management from another discipline. It also does not replace the treatment of established chronic diseases. The assessment determines whether an indication exists.

Can a regenerative medicine assessment be done remotely?

Yes. At Longevia Medical, the assessment can be in person at Puerto Cancún or remote. In both cases, the result is an individual written plan. Follow-up can also continue remotely once the patient returns to their city.

For those who want to continue reading on the topic from general patient-facing sources, Mayo Clinic and MedlinePlus offer reference health information.

If you arrive at this field with symptoms that include sudden changes in vision, difficulty breathing, chest pain, or any new neurological symptom, that requires emergency care immediately, not a scheduled consultation.

Regenerative medicine is a real field, with real indications and real limits. Understanding those three dimensions ahead of an assessment is, in our clinical experience, what distinguishes patients who arrive with a concrete objective from those who arrive with an expectation that no protocol can fulfill. The assessment is where that distinction is made, with judgment, with data, and with honesty.